Myasthenia Gravis Presenting as Graft versus Host Disease after Allogeneic Blood Stem Cell Transplant
- PMID: 30116647
- PMCID: PMC6079576
- DOI: 10.1155/2018/7296930
Myasthenia Gravis Presenting as Graft versus Host Disease after Allogeneic Blood Stem Cell Transplant
Abstract
Myasthenia gravis is a very rare manifestation of graft versus host disease after stem cell transplants. Herein, we describe a case of new-onset myasthenia gravis after a stem cell transplant 34 months ago in a patient with myelodysplastic syndrome.
References
-
- Mackey J. R., Desai S., Larratt L., Cwik V., Nabholtz J. M. Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature. Bone Marrow Transplantation. 1997;19(9):939–942. doi: 10.1038/sj.bmt.1700759. - DOI - PubMed
-
- Zaja F., Barillari G., Russo D., Silvestri F., Fanin R., Baccarani M. Myasthenia gravis after allogeneic bone marrow transplantation: a case report. Bone Marrow Transplantation. 1995;15(4):649–650. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
